JPWO2020185796A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020185796A5 JPWO2020185796A5 JP2021554674A JP2021554674A JPWO2020185796A5 JP WO2020185796 A5 JPWO2020185796 A5 JP WO2020185796A5 JP 2021554674 A JP2021554674 A JP 2021554674A JP 2021554674 A JP2021554674 A JP 2021554674A JP WO2020185796 A5 JPWO2020185796 A5 JP WO2020185796A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- cells
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962816746P | 2019-03-11 | 2019-03-11 | |
| US62/816,746 | 2019-03-11 | ||
| PCT/US2020/021916 WO2020185796A1 (en) | 2019-03-11 | 2020-03-10 | High avidity wt1 t cell receptors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525099A JP2022525099A (ja) | 2022-05-11 |
| JPWO2020185796A5 true JPWO2020185796A5 (US20100268047A1-20101021-C00003.png) | 2023-03-17 |
Family
ID=70155376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554674A Pending JP2022525099A (ja) | 2019-03-11 | 2020-03-10 | 高アビディティｗｔ１ｔ細胞受容体とその使用 |
Country Status (13)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY192819A (en) | 2016-12-08 | 2022-09-12 | Immatics Biotechnologies Gmbh | Novel t cell receptors and immune therapy using the same |
| CA3203118A1 (en) * | 2020-12-31 | 2022-07-07 | Gagan BAJWA | Cd8 polypeptides, compositions, and methods of using thereof |
| WO2024088383A1 (en) * | 2022-10-28 | 2024-05-02 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Anti-wt1/hla antibodies and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| ES2292994T3 (es) | 2002-03-15 | 2008-03-16 | Cellectis | Meganucleasas hibridas y de cadena sencilla y su utilizacion. |
| JP4966006B2 (ja) | 2003-01-28 | 2012-07-04 | セレクティス | カスタムメイドメガヌクレアーゼおよびその使用 |
| EP1850860A2 (en) | 2005-01-13 | 2007-11-07 | The Johns Hopkins University | Prostate stem cell antigen vaccines and uses thereof |
| EP1945762B1 (en) | 2005-10-18 | 2013-05-01 | Precision Biosciences | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| EP2210903A1 (en) | 2009-01-21 | 2010-07-28 | Monoclonal Antibodies Therapeutics | Anti-CD160 monoclonal antibodies and uses thereof |
| EP2258719A1 (en) | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| US8586526B2 (en) | 2010-05-17 | 2013-11-19 | Sangamo Biosciences, Inc. | DNA-binding proteins and uses thereof |
| AU2012296613B2 (en) | 2011-08-15 | 2016-05-12 | Amplimmune, Inc. | Anti-B7-H4 antibodies and their uses |
| GB2537000C (en) | 2012-05-25 | 2019-10-09 | Univ California | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| DK2921557T3 (en) | 2012-12-12 | 2016-11-07 | Broad Inst Inc | Design of systems, methods and optimized sequence manipulation guide compositions |
| SG11201504764SA (en) | 2012-12-19 | 2015-07-30 | Amplimmune Inc | Anti-human b7-h4 antibodies and their uses |
| AU2014350051A1 (en) | 2013-11-18 | 2016-07-07 | Crispr Therapeutics Ag | CRISPR-Cas system materials and methods |
| CN106804108B (zh) | 2014-09-12 | 2021-08-10 | 基因泰克公司 | 抗-b7-h4抗体及免疫缀合物 |
| WO2016054638A1 (en) | 2014-10-03 | 2016-04-07 | Dana-Farber Cancer Institute, Inc. | Glucocorticoid-induced tumor necrosis factor receptor (gitr) antibodies and methods of use thereof |
| HUE061084T2 (hu) | 2015-02-19 | 2023-05-28 | Compugen Ltd | PVRIG elleni antitestek és alkalmazási eljárások |
| CA3177938A1 (en) | 2015-03-05 | 2016-09-09 | Fred Hutchinson Cancer Center | Immunomodulatory fusion proteins and uses thereof |
| JO3620B1 (ar) | 2015-08-05 | 2020-08-27 | Amgen Res Munich Gmbh | مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم |
| US11047011B2 (en) * | 2015-09-29 | 2021-06-29 | iRepertoire, Inc. | Immunorepertoire normality assessment method and its use |
| WO2017112944A1 (en) * | 2015-12-23 | 2017-06-29 | Fred Hutchinson Cancer Research Center | High affinity t cell receptors and uses thereof |
| CN110785432A (zh) * | 2017-04-24 | 2020-02-11 | 圣拉斐尔医院有限责任公司 | Tcr和肽 |
-
2020
- 2020-03-10 CA CA3132845A patent/CA3132845A1/en active Pending
- 2020-03-10 MX MX2021010837A patent/MX2021010837A/es unknown
- 2020-03-10 WO PCT/US2020/021916 patent/WO2020185796A1/en unknown
- 2020-03-10 KR KR1020217032466A patent/KR20210138043A/ko unknown
- 2020-03-10 SG SG11202109745P patent/SG11202109745PA/en unknown
- 2020-03-10 JP JP2021554674A patent/JP2022525099A/ja active Pending
- 2020-03-10 CN CN202080033281.4A patent/CN113784978A/zh active Pending
- 2020-03-10 US US17/438,380 patent/US20220160764A1/en active Pending
- 2020-03-10 BR BR112021017703A patent/BR112021017703A8/pt unknown
- 2020-03-10 AU AU2020237043A patent/AU2020237043A1/en not_active Abandoned
- 2020-03-10 EA EA202192252A patent/EA202192252A1/ru unknown
- 2020-03-10 EP EP20716656.2A patent/EP3938386A1/en active Pending
-
2021
- 2021-09-09 IL IL286202A patent/IL286202A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Houot et al. | T-cell–based immunotherapy: adoptive cell transfer and checkpoint inhibition | |
| Schooten et al. | MAGE-A antigens as targets for cancer immunotherapy | |
| JP2017523784A5 (US20100268047A1-20101021-C00003.png) | ||
| JP2018510627A5 (US20100268047A1-20101021-C00003.png) | ||
| Junghans | The challenges of solid tumor for designer CAR-T therapies: a 25-year perspective | |
| Schadendorf et al. | Immunotherapy of distant metastatic disease | |
| Stern et al. | CAR T cell therapy progress and challenges for solid tumors | |
| Zhang et al. | Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer | |
| KR20220108215A (ko) | 암의 치료용 조합 제조물 | |
| US20230080443A1 (en) | Immunogenic compounds for cancer therapy | |
| Franks et al. | New anticancer immunotherapies | |
| CN110022893B (zh) | 用于癌症疗法的免疫原性化合物 | |
| JPWO2020185796A5 (US20100268047A1-20101021-C00003.png) | ||
| Madany et al. | Immunobiology and immunotherapeutic targeting of glioma stem cells | |
| JP2001514190A (ja) | 細胞傷害性ｔ細胞免疫を引き出すペプチド | |
| JPWO2020193767A5 (US20100268047A1-20101021-C00003.png) | ||
| US20100008980A1 (en) | Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer | |
| Magnani et al. | Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives | |
| TWI785426B (zh) | 包含含有il-2蛋白及cd80蛋白之融合蛋白與自然殺手細胞的用於治療癌症的藥學組成物 | |
| di Pietro et al. | Oncophage®(vitespen®)-Heat shock protein peptide complex 96-based vaccines in melanoma: How far we are, how far we can get? | |
| KR102624844B1 (ko) | 암의 향상된 치료 | |
| Tardif et al. | Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia | |
| JPWO2020252218A5 (US20100268047A1-20101021-C00003.png) | ||
| KR20200038942A (ko) | 약학적 키트 및 그의 용도 | |
| Subklewe | Current status of immunotherapy in acute myeloid leukemia |
